Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member, CEO, Chairman
2026-03-20–present
Youngjik Cho
Equibles does not estimate personal net worth.
Get an email with a short summary when Apimeds Pharmaceuticals US, Inc. publishes a filing, an earnings call transcript or a press release.
Get APUS alertsAbout Youngjik Cho
Youngjik Cho is recorded as Board Member, CEO and Chairman at Apimeds Pharmaceuticals US, Inc. (APUS) since March 20, 2026. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed March 25, 2026 that Youngjik Cho was appointed Chairman of the Board, effective March 20, 2026. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed March 25, 2026 that Youngjik Cho was appointed Chief Executive Officer, effective March 20, 2026. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed March 25, 2026 that Youngjik Cho was appointed Director, effective March 20, 2026. Apimeds Pharmaceuticals US, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Apimeds Pharmaceuticals US, Inc. includes Sungjoon Chae (CEO and Board Member), Vin Menon (CEO and Board Member), Eric Sherb (CFO) and 3 others.
“Mr. Cho was appointed to serve as Chairman of the Board.”
“Mr. Cho was appointed as the new Chief Executive Officer of the Company and Mr. Yu as Secretary of the Company, effective immediately.”
Affiliation history
-
Current
2026-03-20–present
-
Current
2026-03-20–present
-
Current
2026-03-20–present
Company network
Leadership on record at Apimeds Pharmaceuticals US, Inc.
- Sungjoon Chae CEO, Board Member
- Vin Menon CEO, Board Member
- Eric Sherb CFO
- Amir Dossal Board Member
- Junyoung Yu Board Member
- Minguk Ji Board Member